Back to company

15-Bio ApS: Financial statements 2024

CVR: 39889277

15-Bio ApS (CVR 39889277) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -8,126 and a net result of DKK -8,126 compared with DKK -5,001 the year before. Equity amounted to DKK 18,422. The solvency ratio was 41%.

Gross Profit
-8,126 kr.
Profit/Loss
-8,126 kr.
Equity
18,422 kr.
Total Assets
44,880 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--8 t.-8 t.18 t.-
2023--5 t.-5 t.27 t.-
2022--5 t.-4 t.32 t.-
2021--6 t.-7 t.35 t.-
2020--1 t.-1 t.42 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is 15-Bio ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2024

15-Bio ApS: The 2023 annual report is outJun 11, 2024

15-Bio ApS has published its annual report for 2023. Gross profit came to DKK -5,001, and the net result was DKK -5,001.

About 15-Bio ApS

15-Bio ApS is a Danish company of the type Anpartsselskab based in Værløse, founded in 2018. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named Rasmus Jorgensen Holdings ApS and Rasmus Jorgensen IVS. The management consists of Rasmus Jørgensen. The company is owned by Rasmus Jørgensen. In 2025, the company reported a gross profit of DKK -6,875 and a net result of DKK -6,875 compared with DKK -8,126 the year before. Equity amounted to DKK 11,547.

Other financial years